Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CEFTAZIDIME vs CEFUROXIME: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CEFTAZIDIME vs CEFUROXIME: Safety Overview

Metric CEFTAZIDIME CEFUROXIME
Total FAERS Reports 3,158 5,209
Deaths Reported 696 439
Death Rate 22.0% 8.4%
Hospitalizations 1,503 2,274
Average Patient Age 52.0 yrs 56.6 yrs
% Female Patients 43.3% 45.1%
FDA Approval Date Apr 28, 1989 Apr 16, 1998
Manufacturer Hospira, Inc. Sagent Pharmaceuticals
Route INTRAVENOUS INTRAMUSCULAR
Marketing Status Discontinued Discontinued